Evidence map›Paper›PMID 30585438›Full record

Trial reportPediatric pulmonology2019

Longitudinal analysis of bronchodilator response in asthmatics and effect modification of age-related trends by genotype.

Joanne E Sordillo, Michael McGeachie, Sharon M Lutz, Jessica Lasky-Su, Kelan Tantisira, Ching Hui Tsai, Amber Dahlin, Rachel Kelly, Ann Chen Wu

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Pediatric pulmonology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Pharmacogenetics of Bronchodilator Response: Future Directions.Current allergy and asthma reports · 2021
    Review
  3. Article
  4. Genetic Determinants of Poor Response to Treatment in Severe Asthma.International journal of molecular sciences · 2021
    Review
  5. Article
  6. Review
  7. Pharmacogenetics of Pediatric Asthma: Current Perspectives.Pharmacogenomics and personalized medicine · 2020
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Joanne E SordilloDepartment of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA.ORCID 0000-0002-4966-1796
Michael McGeachieChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA.
Sharon M LutzDepartment of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA.
Jessica Lasky-SuChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA.
Kelan TantisiraChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA.
Ching Hui TsaiInstitute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Amber DahlinChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA.
Rachel KellyChanning Division of Network Medicine, Brigham and Women's Hospital, Boston, MA.
Ann Chen WuDepartment of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA.

Funding

THE PHARMACOGENETICS OF ASTHMA TREATMENTU01HL065899 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI TANTISIRA, KELAN G, WEISS, SCOTT T · 2000 to 2014
$38.5M
Integrative Metabolomics of Asthma SeverityR01HL123915 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LASKY-SU, JESSICA A · 2014 to 2023
$7.0M
Asthma Exacerbations and MicroRNA prediction: Treatment Response in an Underserved Ethnicity (AEM-TRUE)R01HL139634 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MCGEACHIE, MICHAEL JOHN · 2018 to 2022
$4.3M
Mechanistic insights into asthma pathogenesis through the integration of asthma genes, risk exposures, and metabolomicsR01HL141826 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI LASKY-SU, JESSICA A · 2018 to 2021
$3.4M
Age-Dependent Pharmacogenomics of Asthma Treatment (ADAPT)R01HD085993 · NICHD · HARVARD PILGRIM HEALTH CARE, INC. · PI WU, ANN CHEN · 2016 to 2020
$3.1M
Role of microRNA molecules in therapeutic response to leukotriene modifying agents in asthmaK01HL130629 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI DAHLIN, AMBER · 2016 to 2020
$818k
An Integrative Genomics Approach to Gene by Environment Interactions in AsthmaR00HL109162 · NHLBI · HARVARD PILGRIM HEALTH CARE, INC. · PI SORDILLO, JOANNE ELAINE · 2014 to 2016
$743k
NHLBI NIH HHS K01 HL130629NHLBI NIH HHS R00 HL109162NHLBI NIH HHS R01 HL123915NHLBI NIH HHS R01 HL139634NHLBI NIH HHS R01 HL141826NHLBI NIH HHS U01 HL065899NICHD NIH HHS R01 HD085993NIH HHS R00HL109162NIH HHS R01HD085993NIH HHS U01HL065899
6 · The paper itself

Abstract

BACKGROUND AND

objectivesGenome Wide Association Studies (GWAS) have identified genetic polymorphisms associated with bronchodilator response (BDR), but it is unknown how these associations change across life stages. We examined the impact of genetic variants on BDR from childhood to adulthood in asthmatics to uncover potential effect modification by age.

methodsWe searched the National Human Genome Research Institute (NHGRI) catalog of published GWAS to obtain a list of genetic associations with BDR, and tested them for effect modification by age in 604 subjects from the Childhood Asthma Management Program (CAMP), a clinical trial with longitudinal measures of BDR (age range 5-30 years). We performed longitudinal analyses using linear mixed models and visualized longitudinal changes in BDR using generalized additive models with repeated measures, adjusting for treatment group, sex, and main effects of age and additive genotype.

resultsIncreasing age was associated with decreased BDR (-0.24% per year). Polymorphisms rs295137 (T allele) near SPATS2L and rs2626393 (C allele) near ASB3 demonstrated their strongest associations with BDR in early childhood through adolescence, with a large decrease in their magnitude of effect from adolescence onward. The effect estimate for % BDR associated with rs295137 genotype (Beta = 1.3; 95%CI 0.6-2.1) was diminished by age (interaction term = -0.06, P = 0.004). The effect estimate for rs2626393 (Beta = -0.92 (95%CI -1.7 to -0.2) was also modified by age (interaction term = 0.05, P = 0.0004).

conclusionsPolymorphisms associated with BDR in childhood may not be relevant for predicting adolescent and adult BDR, which could reflect age-related changes in asthma phenotypes.

Indexed as

AdolescentAdultAgingAsthmaBronchodilator AgentsChildChild, PreschoolEffect Modifier, EpidemiologicFemaleGenome-Wide Association StudyGenotypeHumansMaleTreatment OutcomeYoung AdultBronchodilator Agentsageasthmabronchodilator response

Identifiers

PMID30585438
PMCPMC6818258

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.